The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers , but there were inconsistent associations with blood pressure , adiposity , insulin resistance , and blood lipids .
CONCLUSIONS Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health .
BACKGROUND The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress , but evidence has not systematic ally been evaluated .
OBJECTIVE We aim ed to evaluate systematic ally the effects of lutein ( intake or concentrations ) on cardiometabolic outcomes in different life stages .
Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke
Background and Purpose — Intake of fruits and vegetables has been related to lower risk of ischemic stroke , but nutrients responsible for this apparent benefit remain ill-defined . Tocopherols ( vitamin E ) have also been proposed to be protective . Methods — We conducted a prospect i ve , nested case-control analysis among male physicians without diagnosed cardiovascular disease followed-up for up to 13 years in the Physicians ’ Health Study . Sample s from 297 physicians with ischemic stroke were analyzed with paired controls , matched for age and smoking , for 5 major carotenoids ( & agr;- and β-carotene , β-cryptoxanthin , lutein , and lycopene ) , retinol , and & agr;- and γ-tocopherol . Results — Baseline plasma levels of & agr;-carotene and β-carotene and lycopene tended to be inversely related to risk of ischemic stroke with an apparent threshold effect . As compared with men whose plasma levels were in the lowest quintile , the multivariate adjusted odds ratios ( ORs ) of ischemic stroke among men with levels in the second through fifth quintiles were 0.59 ( 95 % CI , 0.36 to 0.98 ) for & agr;-carotene , 0.62 ( 95 % CI , 0.38 to 1.01 ) for β-carotene , and 0.61 ( 95 % CI , 0.37 to 1.00 ) for lycopene . A tendency toward an inverse association was found for β-cryptoxanthin , but the result was not statistically significant . No association was found for lutein , retinol , and tocopherols . Conclusion — Our data suggest that higher plasma levels of carotenoids , as markers of fruit and vegetable intake , are inversely related to risk of ischemic stroke and provide support for recommendations to consume fruits and vegetables regularly
The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers , but there were inconsistent associations with blood pressure , adiposity , insulin resistance , and blood lipids .
CONCLUSIONS Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health .
BACKGROUND The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress , but evidence has not systematic ally been evaluated .
OBJECTIVE We aim ed to evaluate systematic ally the effects of lutein ( intake or concentrations ) on cardiometabolic outcomes in different life stages .